125 related articles for article (PubMed ID: 3418492)
1. Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs.
Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
J Pharmacokinet Biopharm; 1988 Apr; 16(2):151-9. PubMed ID: 3418492
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.
Waschek JA; Fielding RM; Pond SM; Rubin GM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1985 Aug; 234(2):431-4. PubMed ID: 4020679
[TBL] [Abstract][Full Text] [Related]
3. Extrahepatic extraction of salicylamide in dogs.
Fielding RM; Waschek JA; Effeney DJ; Pogany AC; Pond SM; Tozer TN
J Pharmacol Exp Ther; 1986 Jan; 236(1):97-102. PubMed ID: 3941404
[TBL] [Abstract][Full Text] [Related]
4. Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes.
Koike M; Sugeno K; Hirata M
J Pharm Sci; 1981 Mar; 70(3):308-11. PubMed ID: 7264898
[TBL] [Abstract][Full Text] [Related]
5. Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition.
Pond SM; Mahachai V; Effeney DJ; Tozer TN
J Pharmacokinet Biopharm; 1988 Apr; 16(2):161-4. PubMed ID: 3418493
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
[TBL] [Abstract][Full Text] [Related]
8. Availability of plasma sulfate for conjugation of salicylamide in dogs.
Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
Biochem Pharmacol; 1986 Feb; 35(3):544-6. PubMed ID: 3947388
[No Abstract] [Full Text] [Related]
9. Effect of route of administration on competitive drug biotransformation interaction: salicylamide-ascorbic acid interaction in rats.
Houston JB; Levy G
J Pharmacol Exp Ther; 1976 Aug; 198(2):284-94. PubMed ID: 948026
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers.
Abdel-Rahman MS; Reddi AS; Curro FA; Turkall RM; Kadry AM; Hansrote JA
Can J Physiol Pharmacol; 1991 Oct; 69(10):1436-42. PubMed ID: 1777842
[TBL] [Abstract][Full Text] [Related]
11. Radiochemical plasma salicylamide assay using ring-labeled tritiated salicylamide.
Stella VJ; Varia SA; Riedy M
J Pharm Sci; 1979 May; 68(5):648-50. PubMed ID: 430509
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
Pang KS; Barker F; Schwab AJ; Goresky CA
J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
[TBL] [Abstract][Full Text] [Related]
13. Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.
Wein S; Cermak R; Wolffram S; Langguth P
Xenobiotica; 2012 May; 42(5):477-82. PubMed ID: 22188411
[TBL] [Abstract][Full Text] [Related]
14. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study.
Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS
Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359
[TBL] [Abstract][Full Text] [Related]
15. Comparison of salicylamide and acetaminophen and their prodrug disposition in dogs.
Podder SK; Nakamura T; Nakashima M; Sasaki H; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1988 May; 11(5):324-9. PubMed ID: 3171875
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of salicylamide in the intestinal wall of dogs and rabbits.
Podder SK; Nakashima M; Nakamura T; Sasaki H; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1986 Nov; 9(11):917-22. PubMed ID: 3559882
[TBL] [Abstract][Full Text] [Related]
17. Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat.
Knight E; Van Wart J; Roe DA
J Nutr; 1978 Feb; 108(2):216-25. PubMed ID: 621578
[TBL] [Abstract][Full Text] [Related]
18. First-pass elimination of salicylamide in man following oral and rectal administration.
de Boer AG; Breimer DD; Gubbens-Stibbe JM; Bosma A
Biopharm Drug Dispos; 1983; 4(4):321-30. PubMed ID: 6689276
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of Eudragit gels. VI: In vivo evaluation of Eudispert rectal hydrogel and xerogel containing salicylamide.
Umejima H; Kim NS; Ito T; Uchida T; Goto S
J Pharm Sci; 1993 Feb; 82(2):195-9. PubMed ID: 8445535
[TBL] [Abstract][Full Text] [Related]
20. Effect of salicylamide on skeletal glycosaminoglycan sulfation and calcification in fetal rat limbs.
Halstead PK; Roe DA
Drug Nutr Interact; 1981; 1(1):75-86. PubMed ID: 6821388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
